| 0 |
BLOOD GLUCAGON INCREASED |
1 |
0.0217 |
| 1 |
PUNCTURE SITE BRUISE |
1 |
0.0196 |
| 2 |
SPINAL CORD HERNIATION |
1 |
0.0066 |
| 3 |
MOUTH BREATHING |
1 |
0.0023 |
| 4 |
OESOPHAGEAL FOOD IMPACTION |
1 |
0.0018 |
| 5 |
STREPTOCOCCAL BACTERAEMIA |
1 |
0.0009 |
| 6 |
TONSILLAR HYPERTROPHY |
1 |
0.0006 |
| 7 |
BILIARY DYSKINESIA |
1 |
0.0006 |
| 8 |
NASAL OEDEMA |
1 |
0.0006 |
| 9 |
EOSINOPHILIC OESOPHAGITIS |
1 |
0.0004 |
| 10 |
BLOOD BLISTER |
1 |
0.0003 |
| 11 |
INJECTION SITE HYPERSENSITIVITY |
1 |
0.0003 |
| 12 |
NON-CARDIAC CHEST PAIN |
1 |
0.0003 |
| 13 |
OEDEMA MOUTH |
1 |
0.0003 |
| 14 |
RENAL TRANSPLANT |
1 |
0.0003 |
| 15 |
APHAGIA |
1 |
0.0002 |
| 16 |
EXPIRED DRUG ADMINISTERED |
1 |
0.0002 |
| 17 |
GASTROINTESTINAL SOUNDS ABNORMAL |
1 |
0.0002 |
| 18 |
KLEBSIELLA INFECTION |
1 |
0.0002 |
| 19 |
INCREASED UPPER AIRWAY SECRETION |
1 |
0.0002 |
| 20 |
COMPRESSION FRACTURE |
1 |
0.0002 |
| 21 |
THERAPEUTIC RESPONSE CHANGED |
1 |
0.0002 |
| 22 |
POLYP |
1 |
0.0002 |
| 23 |
TENDON PAIN |
1 |
0.0001 |
| 24 |
ECONOMIC PROBLEM |
2 |
0.0001 |
| 25 |
BRONCHOPULMONARY ASPERGILLOSIS |
1 |
0.0001 |
| 26 |
NEPHROPATHY |
1 |
0.0001 |
| 27 |
VAGINAL DISCHARGE |
1 |
0.0001 |
| 28 |
OESOPHAGITIS |
1 |
0.0001 |
| 29 |
CHOLECYSTECTOMY |
1 |
0.0001 |
| 30 |
CAESAREAN SECTION |
1 |
0.0001 |
| 31 |
ANHEDONIA |
2 |
0.0001 |
| 32 |
ORAL DISCOMFORT |
1 |
0.0001 |
| 33 |
HYPERTHYROIDISM |
1 |
0.0001 |
| 34 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 35 |
GENERALISED TONIC-CLONIC SEIZURE |
1 |
0.0001 |
| 36 |
METRORRHAGIA |
1 |
0.0001 |
| 37 |
SCAR |
1 |
0.0001 |
| 38 |
LOCAL SWELLING |
1 |
0.0001 |
| 39 |
END STAGE RENAL DISEASE |
1 |
0.0001 |
| 40 |
FOOT FRACTURE |
1 |
0.0001 |
| 41 |
GASTRIC ULCER |
1 |
0.0001 |
| 42 |
HAEMORRHOIDS |
1 |
0.0001 |
| 43 |
INJECTION SITE WARMTH |
1 |
0.0000 |
| 44 |
TOOTH LOSS |
1 |
0.0000 |
| 45 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 46 |
FEBRILE NEUTROPENIA |
3 |
0.0000 |
| 47 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
1 |
0.0000 |
| 48 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 49 |
CONTUSION |
4 |
0.0000 |
| 50 |
SKIN ULCER |
1 |
0.0000 |
| 51 |
SEDATION |
1 |
0.0000 |
| 52 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 53 |
WOUND |
1 |
0.0000 |
| 54 |
PAIN IN JAW |
1 |
0.0000 |
| 55 |
BONE PAIN |
2 |
0.0000 |
| 56 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 57 |
BONE DENSITY DECREASED |
1 |
0.0000 |
| 58 |
HEART RATE DECREASED |
1 |
0.0000 |
| 59 |
DRUG EFFECT INCOMPLETE |
1 |
0.0000 |
| 60 |
RESTLESSNESS |
1 |
0.0000 |
| 61 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 62 |
CHRONIC KIDNEY DISEASE |
2 |
0.0000 |
| 63 |
ABORTION SPONTANEOUS |
1 |
0.0000 |
| 64 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 65 |
POLLAKIURIA |
1 |
0.0000 |
| 66 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 67 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 68 |
CARDIAC DISORDER |
2 |
0.0000 |
| 69 |
THERAPY CESSATION |
1 |
0.0000 |
| 70 |
ECZEMA |
1 |
0.0000 |
| 71 |
SPEECH DISORDER |
1 |
0.0000 |
| 72 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 73 |
FLATULENCE |
1 |
0.0000 |
| 74 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 75 |
ABDOMINAL PAIN |
4 |
0.0000 |
| 76 |
SURGERY |
1 |
0.0000 |
| 77 |
NASAL CONGESTION |
1 |
0.0000 |
| 78 |
EMOTIONAL DISTRESS |
2 |
0.0000 |
| 79 |
STOMATITIS |
1 |
0.0000 |
| 80 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 81 |
CHEST PAIN |
3 |
0.0000 |
| 82 |
INJECTION SITE ERYTHEMA |
2 |
0.0000 |
| 83 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 84 |
PRODUCT USE ISSUE |
3 |
0.0000 |
| 85 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 86 |
RENAL FAILURE |
2 |
0.0000 |
| 87 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 88 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 89 |
ABDOMINAL PAIN UPPER |
3 |
0.0000 |
| 90 |
INJURY |
1 |
0.0000 |
| 91 |
CONSTIPATION |
3 |
0.0000 |
| 92 |
UNDERDOSE |
1 |
0.0000 |
| 93 |
WEIGHT INCREASED |
3 |
0.0000 |
| 94 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 95 |
ACUTE KIDNEY INJURY |
2 |
0.0000 |
| 96 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 97 |
DRY MOUTH |
1 |
0.0000 |
| 98 |
TREATMENT FAILURE |
1 |
0.0000 |
| 99 |
MYALGIA |
2 |
0.0000 |
| 100 |
BALANCE DISORDER |
1 |
0.0000 |
| 101 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 102 |
HYPERSENSITIVITY |
2 |
0.0000 |
| 103 |
SWELLING |
1 |
0.0000 |
| 104 |
PRURITUS |
4 |
0.0000 |
| 105 |
ALOPECIA |
2 |
0.0000 |
| 106 |
DYSPEPSIA |
1 |
0.0000 |
| 107 |
DIZZINESS |
5 |
0.0000 |
| 108 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 109 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 110 |
SEIZURE |
1 |
0.0000 |
| 111 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 112 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 113 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 114 |
DEHYDRATION |
1 |
0.0000 |
| 115 |
VISION BLURRED |
1 |
0.0000 |
| 116 |
ANXIETY |
2 |
0.0000 |
| 117 |
RASH |
3 |
0.0000 |
| 118 |
CONDITION AGGRAVATED |
2 |
0.0000 |
| 119 |
PAIN |
4 |
0.0000 |
| 120 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 121 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 122 |
URTICARIA |
1 |
0.0000 |
| 123 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 124 |
COVID-19 |
1 |
0.0000 |
| 125 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 126 |
MUSCLE SPASMS |
1 |
0.0000 |
| 127 |
ANAEMIA |
1 |
0.0000 |
| 128 |
SOMNOLENCE |
1 |
0.0000 |
| 129 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 130 |
ERYTHEMA |
1 |
0.0000 |
| 131 |
ARTHRALGIA |
2 |
0.0000 |
| 132 |
HEADACHE |
3 |
0.0000 |
| 133 |
DIARRHOEA |
3 |
0.0000 |
| 134 |
MALAISE |
2 |
0.0000 |
| 135 |
DRUG INEFFECTIVE |
6 |
0.0000 |
| 136 |
DECREASED APPETITE |
1 |
0.0000 |
| 137 |
FEELING ABNORMAL |
1 |
0.0000 |
| 138 |
FATIGUE |
3 |
0.0000 |
| 139 |
INSOMNIA |
1 |
0.0000 |
| 140 |
WEIGHT DECREASED |
1 |
0.0000 |
| 141 |
DYSPNOEA |
2 |
0.0000 |
| 142 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 143 |
FALL |
1 |
0.0000 |
| 144 |
OFF LABEL USE |
2 |
0.0000 |
| 145 |
NAUSEA |
1 |
0.0000 |
| 146 |
DEATH |
1 |
0.0000 |